Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8629796 | Diabetes Research and Clinical Practice | 2018 | 27 Pages |
Abstract
Progression of CAC was increased in well-treated, normoalbuminuric persons with type 1 diabetes compared to matched controls without diabetes, suggesting that type 1 diabetes is a risk factor for short-term progression. This finding could explain some of the increased morbidity and mortality observed in persons with type 1 diabetes, but it does not specifically explain the increased CV risk in persons with CAN.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Henrik Ã. Hjortkjær, Tonny Jensen, Jannik Hilsted, Helle Corinth, Ulrik M. Mogensen, Lars Køber, Andreas Fuchs, Børge G. Nordestgaard, Klaus F. Kofoed,